Authors: Gyorffy, S Palmer, K Podor, TJ Hitt, M Gauldie, J

Citation: S. Gyorffy et al., Combined treatment of a murine breast cancer model with type 5 adenovirus vectors expressing murine angiostatin and IL-12: A role for combined anti-angiogenesis and immunotherapy, J IMMUNOL, 166(10), 2001, pp. 6212-6217

Authors: Kahr, WHA Zheng, SL Sheth, PM Pai, M Cowie, A Bouchard, M Podor, TJ Rivard, GE Hayward, CPM

Citation: Wha. Kahr et al., Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator, BLOOD, 98(2), 2001, pp. 257-265

Authors: Podor, TJ Shaughnessy, SG Blackburn, MN Peterson, CB

Citation: Tj. Podor et al., New insights into the size and stoichiometry of the plasminogen activator inhibitor type-1 vitronectin complex, J BIOL CHEM, 275(33), 2000, pp. 25402-25410

Authors: Podor, TJ Peterson, CB Lawrence, DA Stefansson, S Shaughnessy, SG Foulon, DM Butcher, M Weitz, JI

Citation: Tj. Podor et al., Type 1 plasminogen activator inhibitor binds to fibrin via vitronectin, J BIOL CHEM, 275(26), 2000, pp. 19788-19794

Authors: Young, E Venner, T Ribau, J Shaughnessy, S Hirsh, J Podor, TJ

Citation: E. Young et al., The binding of unfractionated heparin and low molecular weigh heparin to thrombin-activated human endothelial cells, THROMB RES, 96(5), 1999, pp. 373-381

Authors: Outinen, PA Sood, SK Pfeifer, SI Pamidi, S Podor, TJ Li, J Weitz, JI Austin, RC

Citation: Pa. Outinen et al., Homocysteine-induced endoplasmic reticulum stress and growth arrest leads to specific changes in gene expression in human vascular endothelial cells, BLOOD, 94(3), 1999, pp. 959-967